Increasing proportions of extended-spectrum β-lactamase-producing isolates among Escherichia coli from urine and bloodstream infections: results from a nationwide surveillance network, Finland, 2008 to 2019

Whole-Genome Sequencing of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli From Human Infections in Finland Revealed Isolates Belonging to Internationally Successful ST131-C1-M27 Subclade but Distinct From Non-human Sources

(2022) Paula Kurittu et al.   Frontiers in Microbiology

Urinary culture sensitivity after a single empirical antibiotic dose for upper or febrile urinary tract infection: A prospective multicentre observational study

(2022) Gregor John et al.   CLINICAL MICROBIOLOGY AND INFECTION

Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study

(2021) Melissa C. MacKinnon et al.   BMC INFECTIOUS DISEASES

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management

(2021) Keith S Kaye et al.   CLINICAL INFECTIOUS DISEASES

Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

(2021) Eva Raphael et al.   Antimicrobial Resistance and Infection Control

Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study

(2021) Melissa C. MacKinnon et al.   Antimicrobial Resistance and Infection Control

Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review

(2020) Marc Bonten et al.   CLINICAL INFECTIOUS DISEASES

Monitoring Antimicrobial Resistance and Drug Usage in the Human and Livestock Sector and Foodborne Antimicrobial Resistance in Six European Countries

(2020) Octavio Mesa Varona et al.   Infection and Drug Resistance

Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel

(2019) Isabel Frost et al.   JOURNAL OF TRAVEL MEDICINE

Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period

(2019) A. A. van Driel et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study

(2019) Maris S. Arcilla et al.   Travel Medicine and Infectious Disease

Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study

(2017) Maris S Arcilla et al.   LANCET INFECTIOUS DISEASES

Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae

(2015) A. Kantele et al.   CLINICAL INFECTIOUS DISEASES

Nosocomial bloodstream infections caused byEscherichia coliandKlebsiellapneumoniaeresistant to third-generation cephalosporins, Finland, 1999–2013: Trends, patient characteristics and mortality

(2015) Timi Martelius et al.   Infectious Diseases

Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007–2011

(2013) A. Brolund et al.   CLINICAL MICROBIOLOGY AND INFECTION

Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis

(2009) Jesús Rodríguez‐Baño et al.   CLINICAL INFECTIOUS DISEASES

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: Importance of international travel

(2008) Kevin B. Laupland et al.   JOURNAL OF INFECTION